...
首页> 外文期刊>Nature Communications >Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein
【24h】

Negative regulation of EGFR signalling by the human folliculin tumour suppressor protein

机译:人类卵泡抑素蛋白对EGFR信号转导的负调控

获取原文
           

摘要

Germline mutations in the Folliculin ( FLCN ) tumour suppressor gene result in fibrofolliculomas, lung cysts and renal cancers, but the precise mechanisms of tumour suppression by FLCN remain elusive. Here we identify Rab7A, a small GTPase important for endocytic trafficking, as a novel FLCN interacting protein and demonstrate that FLCN acts as a Rab7A GTPase-activating protein. FLCN?/? cells display slower trafficking of epidermal growth factor receptors (EGFR) from early to late endosomes and enhanced activation of EGFR signalling upon ligand stimulation. Reintroduction of wild-type FLCN, but not tumour-associated FLCN mutants, suppresses EGFR signalling in a Rab7A-dependent manner. EGFR signalling is elevated in FLCN?/? tumours and the EGFR inhibitor afatinib suppresses the growth of human FLCN?/? cells as tumour xenografts. The functional interaction between FLCN and Rab7A appears conserved across species. Our work highlights a mechanism explaining, at least in part, the tumour suppressor function of FLCN.
机译:Folliculin(FLCN)抑癌基因中的种系突变导致纤维滤泡瘤,肺囊肿和肾癌,但是通过FLCN抑制肿瘤的确切机制仍然难以捉摸。在这里,我们将Rab7A(一种对内吞运输重要的小GTP酶)识别为一种新型FLCN相互作用蛋白,并证明FLCN充当Rab7A GTPase激活蛋白。 FLCN ?/?细胞表现出从早期到晚期内体的表皮生长因子受体(EGFR)的运输较慢,并且在配体刺激后增强了EGFR信号的激活。重新引入野生型FLCN,但不引入与肿瘤相关的FLCN突变体,以Rab7A依赖性方式抑制EGFR信号传导。 EGFR信号在FLCN ?/?肿瘤中升高,而EGFR抑制剂afatinib抑制人FLCN ?/?细胞作为异种移植物的生长。 FLCN和Rab7A之间的功能相互作用在物种间似乎是保守的。我们的工作强调了至少部分解释FLCN的抑癌功能的机制。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号